Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518973
Status:
COMPLETED
Last Update Posted:
2019-07-17
First Post:
2007-08-20
Brief Title:
Trial of Quetiapine in Anorexia Nervosa
Sponsor:
University of California San Diego
Organization:
University of California San Diego
Study Overview
Official Title:
Double-blind Placebo-controlled Trial of Quetiapine in Anorexia Nervosa
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study is being held at UCSD to determine whether the medication Quetiapine helps people suffering from anorexia nervosa by reducing core eating disorders symptoms This study will see if the medication Quetiapine helps symptoms of anxiety depression and obsessionality in addition to increasing BMI Men and women between the ages of 18-65 and are currently suffering from anorexia nervosa are needed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| QUET0376 | None | None | None |